about
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisImpact of Exercise on Innate Immunity in Multiple Sclerosis Progression and SymptomatologyCNS Remyelination and the Innate Immune SystemDouble Roles of Macrophages in Human Neuroimmune Diseases and Their Animal ModelsEvidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Epigenetic Drugs for Multiple SclerosisPeripheral (Seventh) Nerve Palsy and Multiple Sclerosis: A Diagnostic Dilemma - A Case ReportComparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database.Deficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiationThe contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosisThe A Allele of the Single-Nucleotide Polymorphism rs630923 Creates a Binding Site for MEF2C Resulting in Reduced CXCR5 Promoter Activity in B-Cell Lymphoblastic Cell Lines.Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosisPositive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian populationIncreasing consistency of disease biomarker prediction across datasets.Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.Repetitive element hypermethylation in multiple sclerosis patients.Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T.Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunityA novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.Multiple sclerosis presenting initially with a worsening of migraine symptomsAge of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model.Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis PatientsNovel intrathecal and subcutaneous catheter delivery systems in the mouseEffects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosisPrevalence of Cytomegalovirus in Patients With Multiple Sclerosis: A Case-Control Study in Northern IranComparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple SclerosisTherapeutic effects of human adipose tissue-derived stem cell (hADSC) transplantation on experimental autoimmune encephalomyelitis (EAE) mice.Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece--the HOPE II Study[EXPRESS] Topical moringin-cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosis.Optogenetics and its application in neural degeneration and regeneration.Acid-Sensing Ion Channels as Potential Therapeutic Targets in Neurodegeneration and Neuroinflammation.Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.Synthesis of a Bifunctional Peptide Inhibitor-IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis.Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience.Inhibition of myeloperoxidase by N-acetyl lysyltyrosylcysteine amide reduces experimental autoimmune encephalomyelitis-induced injury and promotes oligodendrocyte regeneration and neurogenesis in a murine model of progressive multiple sclerosis.
P2860
Q26740330-8AABAC9B-CEE9-4C52-BCF9-BB83741BADE0Q26745562-041B5C23-CF2D-4C62-BD06-A7227D59B1AEQ26747242-81E3F476-EF23-4E68-AE23-50AFA98A1FCCQ26749131-ADA4C94C-2246-4489-93EE-279A6B06D247Q26770823-3BD8BE83-6848-4A75-A34B-29B798B65F2BQ26779933-605234B5-AC1D-4CDE-A674-28195395B5FCQ26852060-C625E8E3-8C5E-4A69-ADA8-1B49CB42117BQ28076395-962A2B7F-5C7C-4BDB-BD3F-80D15AAA2775Q31051233-79340F61-5454-4EC4-8817-27CBE8F9B244Q33736215-9F357AE5-FD60-4D94-B6D9-5273BC644989Q33920152-55543C47-1846-4F30-9096-AF905DB32DC3Q34413247-6C6D9551-8FB7-4E7D-AAB3-4FD77400B4B6Q34546457-AEFB48C6-E95B-4D6C-95B7-7E6459893369Q34987652-13F2B220-49CF-42BF-89FB-BF2DB1278B68Q35061515-27856B46-7225-4D8B-8837-A845353C9882Q35150852-A6717EE7-A7AC-41A6-AC4A-D064A8ACA925Q35213818-5F7B57EB-4D70-44EC-BAD7-C24648F7F5F1Q35676048-B90BA607-A14F-41E2-8453-F4BA0A01F99CQ36055884-DE82BC20-C37D-4BC4-8417-36A2AF1CE923Q36063128-14D55D18-D719-430F-9556-7DBAC199081DQ36278892-6658EF8F-B65D-40FA-80B0-A9C443BEF61CQ36810081-9FBD906C-EEA7-49B0-ACBF-F80072324007Q37115220-A36D5C03-F9A3-4A53-8E21-2D32A0FE9B8FQ37202733-44FC39CD-7431-4E6B-A11C-FE8A847E37D2Q37232023-3707261D-C0BF-4707-BAB0-26345FCB6876Q37238590-FF939387-E5D4-464A-9191-EDF4C38C2386Q37261686-8B43DC7F-B16B-43F5-B100-E45EA57BC31EQ37280555-B3955585-052D-4947-9A1D-A6B3E1A1CF2FQ37510577-20654ACF-F5F7-4A78-AAA6-7D1FEC981B6EQ37642800-743FB627-9793-49D9-84A1-D77AF5B0ECCDQ38530085-40F238A0-B5F9-4735-9519-DFC5031D172CQ38996589-AC02A26D-0819-4735-A043-6BF011E9E45CQ39959251-8926FBAF-8D2B-426A-BB01-3375D392E13EQ41381440-66066296-0DE0-4EF4-86D2-12D78A48D43AQ41667414-A423B6BE-2A47-484A-838F-6CD63109D33CQ42941036-EE2AB24B-581F-4591-98D0-75133AC5E5DEQ45071794-1AF8F072-8B69-4CB1-962B-B8B13E0CE949Q46299475-1932D77B-57D8-419C-9E4A-8BA862C6CEB6Q47105088-93937347-5579-416E-8BE4-BCB1E232B9CCQ47270053-F8A62E4C-3BA8-4C45-918B-FCED21743C25
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Multiple sclerosis review.
@ast
Multiple sclerosis review.
@en
type
label
Multiple sclerosis review.
@ast
Multiple sclerosis review.
@en
prefLabel
Multiple sclerosis review.
@ast
Multiple sclerosis review.
@en
P2860
P1476
Multiple sclerosis review
@en
P2093
Marvin M Goldenberg
P2860
P304
P577
2012-03-01T00:00:00Z